Liquid biopsy to improve lung cancer screening
Part of Cancer, Lungs & breathing clinical trials.
This study tests whether a simple blood test (liquid biopsy) can help find lung cancer earlier in people at high risk. It also includes people already diagnosed with lung cancer to refine the test.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have never had lung cancer before
- You are a current or former smoker (quit within 15 years), aged 55-74, with at least 30 pack-years of smoking
- Or you are a never-smoker aged 55-75 with a parent, sibling, or child who had lung cancer
- You are willing to give a blood sample and may have a low-dose CT scan
- You have not had a CT scan of your chest in the past year
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining low-dose chest CT scans with blood “biomarker” tests can help find lung cancer earlier in people at higher risk. You may be asked to have scans and blood tests and then attend follow-up visits over time.
This trial uses a simple blood test (liquid biopsy) to find tumor DNA in people suspected of having lung cancer. The goal is to learn if this test can help doctors make better treatment decisions without needing a tissue sample.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
This study looks at whether combining lung images with a blood test (DNA methylation) can help find lung cancer early. It is for people who have a new diagnosis of lung cancer and have not had treatment yet, as well as for people without cancer as a comparison.
This trial uses a new, non-invasive way to screen for lung cancer by combining your breath, blood, and CT scan images. The goal is to figure out whether a nodule found on a CT scan is cancerous or not, which could help patients avoid unnecessary procedures.
This study tests a new chip that may detect lung cancer from a blood sample. It will compare blood from people with lung cancer and people without, possibly helping to find or monitor the disease in the future.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.